Big Pharma At US FDA: A Regulatory Scorecard

The breakthrough designations, approvals, and rejections for applications from the 15 biggest companies in a Pink Sheet infographic.

review package scorecard
• Source: Shutterstock

Since the beginning of 2021, the biggest companies in the pharma industry received a combined total of 51 new product approvals from the US FDA, according to the Pink Sheet’s US FDA Performance Tracker.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from US FDA Performance Tracker

More from Regulatory Trackers